drugset

drugset / Trial / NCT00375570

Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents

NCT00375570 ↗

Phase 3 Completed 254 enrolled Medivir

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The Purpose of this study is to evaluate the safety of ME-609 for the treatment of recurrent herpes labialis in adolescents.

Timeline

Start: 2006-10
Primary completion: 2007-09
Completion: 2007-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ME-609	Unknown	—	Topical

Indications